NCT00554827 2020-01-03Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell LymphomaAcrotech Biopharma Inc.Phase 1 Completed55 enrolled
NCT03349333 2019-10-01A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCLMundipharma (China) Pharmaceutical Co. LtdPhase 3 Completed85 enrolled 26 charts